Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Diabetes Reports
Published in: Current Diabetes Reports 8/2016

01-08-2016 | Psychosocial Aspects (S Jaser and KK Hood, Section Editors)

Fear of Hypoglycemia in Children and Adolescents and Their Parents with Type 1 Diabetes

Authors: Kimberly A. Driscoll, Jennifer Raymond, Diana Naranjo, Susana R. Patton

Published in: Current Diabetes Reports | Issue 8/2016

Login to get access

Abstract

Hypoglycemia is a frequent occurrence in children and adolescents with type 1 diabetes. A variety of efforts have been made to standardize the definition of hypoglycemia and to define one of its most significant psychosocial consequences—fear of hypoglycemia (FOH). In addition to documenting the experience of FOH in children and adolescents type 1 diabetes and their parents, studies have investigated the relations between FOH and glycemic control and diabetes technology use. This review provides a summary of the recent FOH literature as it applies to pediatric type 1 diabetes.
Literature
1.
Shalitin S, Phillip M. Hypoglycemia in type 1 diabetes: a still unresolved problem in the era of insulin analogs and pump therapy. Diabetes Care. 2008;31 Suppl 2:S121–4.CrossRefPubMed
2.
Seaquist ER, Anderson J, Childs B, et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care. 2013;36:1384–95.CrossRefPubMedPubMedCentral
3.
Silverstein J, Klingensmith G, Copeland K, et al. Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care. 2005;28:186–212.CrossRefPubMed
4.
Clarke W, Jones T, Rewers A, et al. Assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes. 2009;10 Suppl 12:134–45.CrossRefPubMed
5.
Gonder-Frederick L, Nyer M, Shepard JA, et al. Assessing fear of hypoglycemia in children with type 1 diabetes and their parents. Diabetes Manag (Lond). 2011;1:627–39.CrossRef
6.
Wild D, von Maltzahn R, Brohan E, et al. A critical review of the literature on fear of hypoglycemia in diabetes: implications for diabetes management and patient education. Patient Educ Couns. 2007;68:10–5.CrossRefPubMed
7.
Barnard K, Thomas S, Royle P, et al. Fear of hypoglycaemia in parents of young children with type 1 diabetes: a systematic review. BMC Pediatr. 2010;10:50.CrossRefPubMedPubMedCentral
8.••
Martyn-Nemeth P, Schwarz Farabi S, Mihailescu D, et al. Fear of hypoglycemia in adults with type 1 diabetes: impact of therapeutic advances and strategies for prevention—a review. J Diabetes Complications. 2016;30:167–77. Review article summarizing the current literature on fear of hypoglycemia in adults with type 1 diabetes.CrossRefPubMed
9.••
Bergenstal RM, Ahmann AJ, Bailey T, et al. Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP). Diabetes Technol Ther. 2013;15:198–211. Proposes standard system for classifying blood glucose levels.CrossRefPubMed
10.
Workgroup on Hypoglycemia ADA. Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care. 2005;28:1245–9.CrossRef
11.
American Diabetes Association. Professional Practice Committee for the Standards of Medical Care in Diabetes—2016. Diabetes Care. 2016;39 Suppl 1:S107–8.
12.
Allen C, LeCaire T, Palta M, et al. Risk factors for frequent and severe hypoglycemia in type 1 diabetes. Diabetes Care. 2001;24:1878–81.CrossRefPubMed
13.
Ferguson SC, Blane A, Perros P, et al. Cognitive ability and brain structure in type 1 diabetes: relation to microangiopathy and preceding severe hypoglycemia. Diabetes. 2003;52:149–56.CrossRefPubMed
14.
Ferguson SC, Blane A, Wardlaw J, et al. Influence of an early-onset age of type 1 diabetes on cerebral structure and cognitive function. Diabetes Care. 2005;28:1431–7.CrossRefPubMed
15.
Northam EA, Rankins D, Lin A, et al. Central nervous system function in youth with type 1 diabetes 12 years after disease onset. Diabetes Care. 2009;32:445–50.CrossRefPubMedPubMedCentral
16.
Geddes J, Wright RJ, Zammitt NN, et al. An evaluation of methods of assessing impaired awareness of hypoglycemia in type 1 diabetes. Diabetes Care. 2007;30:1868–70.CrossRefPubMed
17.
Geddes J, Schopman JE, Zammitt NN, et al. Prevalence of impaired awareness of hypoglycaemia in adults with type 1 diabetes. Diabet Med. 2008;25:501–4.CrossRefPubMed
18.
DCCT. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–86.CrossRef
19.
20.
Weinstock RS, Xing D, Maahs DM, et al. Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D Exchange clinic registry. J Clin Endocrinol Metab. 2013;98:3411–9.CrossRefPubMed
21.
Fox LA, Mubasher M, Wolfsdorf JI, et al. Characteristics of youth with type 1 diabetes with and without a parent with type 1 diabetes in the T1D exchange clinic registry. J Diabetes. 2015.
22.•
Karges B, Kapellen T, Wagner VM et al. Glycated hemoglobin A1c as a risk factor for severe hypoglycemia in pediatric type 1 diabetes. Pediatr Diabetes. 2015. doi:10.​1111/​pedi.​12348. Data presented on the relation between risk for severe hypoglycemia and A1C levels in children and adolescents with type 1 diabetes who were enrolled in the DPV Diabetes Prospective Follow-Up in Germany and Austria
23.
Rewers A, Chase HP, Mackenzie T, et al. Predictors of acute complications in children with type 1 diabetes. JAMA. 2002;287:2511–8.CrossRefPubMed
24.•
Karges B, Rosenbauer J, Kapellen T, et al. Hemoglobin A1c Levels and risk of severe hypoglycemia in children and young adults with type 1 diabetes from Germany and Austria: a trend analysis in a cohort of 37,539 patients between 1995 and 2012. PLoS Med. 2014;11:e1001742. To investigate trends in the association between severe hypoglycemia and glycemic control in the DPV Diabetes Prospective Follow-Up.CrossRefPubMedPubMedCentral
25.
Jeha GS, Karaviti LP, Anderson B, et al. Insulin pump therapy in preschool children with type 1 diabetes mellitus improves glycemic control and decreases glucose excursions and the risk of hypoglycemia. Diabetes Technol Ther. 2005;7:876–84.CrossRefPubMed
26.
Al Hayek AA, Robert AA, Braham RB et al. Predictive risk factors for fear of hypoglycemia and anxiety-related emotional disorders among adolescents with type 1 diabetes. Med Princ Pract. 2015.
27.
Amiri F, Vafa M, Gonder-Frederick L. Glycemic control, self-efficacy and fear of hypoglycemia among Iranian children with type 1 diabetes. Can J Diabetes. 2015;39:302–7.CrossRefPubMed
28.•
Haugstvedt A, Wentzel-Larsen T, Aarflot M, et al. Assessing fear of hypoglycemia in a population-based study among parents of children with type 1 diabetes—psychometric properties of the hypoglycemia fear survey—parent version. BMC Endocr Disord. 2015;15:2. Examination of the psychometric properties of the Hypoglycemia Fear Survey—Parent Version in a sample of Norwegian parents.CrossRefPubMedPubMedCentral
29.
Cox DJ, Irvine A, Gonder-Frederick L, et al. Fear of hypoglycemia: quantification, validation, and utilization. Diabetes Care. 1987;10:617–21.CrossRefPubMed
30.
Weinstock RS, DuBose SN, Bergenstal RM, et al. Risk factors associated with severe hypoglycemia in older adults with type 1 diabetes. Diabetes Care. 2015.
31.
Patton SR, Dolan LM, Henry R, et al. Fear of hypoglycemia in parents of young children with type 1 diabetes mellitus. J Clin Psychol Med Settings. 2008;15:252–9.CrossRefPubMedPubMedCentral
32.
Patton SR, Dolan LM, Henry R, et al. Parental fear of hypoglycemia: young children treated with continuous subcutaneous insulin infusion. Pediatr Diabetes. 2007;8:362–8.CrossRefPubMed
33.
Clarke WL, Gonder-Frederick A, Snyder AL, et al. Maternal fear of hypoglycemia in their children with insulin dependent diabetes mellitus. J Pediatr Endocrinol Metab. 1998;11 Suppl 1:189–94.PubMed
34.
Gonder-Frederick LA, Schmidt KM, Vajda KA, et al. Psychometric properties of the hypoglycemia fear survey-ii for adults with type 1 diabetes. Diabetes Care. 2011;34:801–6.CrossRefPubMedPubMedCentral
35.
Cryer PE. Hypoglycemia. Pathophysiology, diagnosis and treatment. New York: Oxford University Press; 1997.
36.
Green LB, Wysocki T, Reineck BM. Fear of hypoglycemia in children and adolescents with diabetes. J Pediatr Psychol. 1990;15:633–41.CrossRefPubMed
37.••
Shepard JA, Vajda K, Nyer M, et al. Understanding the construct of fear of hypoglycemia in pediatric type 1 diabetes. J Pediatr Psychol. 2014;39:1115–25. Provides additional support for the psychometric properties of the Hypoglycemia Fear Scale for Parents and Children including the demonstration of two subscales of the Behavior scale (Maintain High BG, Avoidance) and two subscales of the Worry scale (Helplessness, Social Consequences).CrossRefPubMedPubMedCentral
38.
Gonder-Frederick LA, Fisher CD, Ritterband LM, et al. Predictors of fear of hypoglycemia in adolescents with type 1 diabetes and their parents. Pediatr Diabetes. 2006;7:215–22.CrossRefPubMed
39.
Kamps JL, Roberts MC, Varela RE. Development of a new fear of hypoglycemia scale: preliminary results. J Pediatr Psychol. 2005;30:287–91.CrossRefPubMed
40.
Johnson SR, Cooper MN, Davis EA, et al. Hypoglycaemia, fear of hypoglycaemia and quality of life in children with type 1 diabetes and their parents. Diabet Med. 2013;30:1126–31.CrossRefPubMed
41.
Freckleton E, Sharpe L, Mullan B. The relationship between maternal fear of hypoglycaemia and adherence in children with type-1 diabetes. Int J Behav Med. 2014;21:804–10.CrossRefPubMed
42.
Haugstvedt A, Wentzel-Larsen T, Graue M, et al. Fear of hypoglycaemia in mothers and fathers of children with type 1 diabetes is associated with poor glycaemic control and parental emotional distress: a population-based study. Diabet Med. 2010;27:72–8.CrossRefPubMed
43.
Snoek FJ, Skinner TC. Psychological counselling in problematic diabetes: does it help? Diabet Med. 2002;19:265–73.CrossRefPubMed
44.
Boyle S, Allan C, Millar K. Cognitive-behavioural interventions in a patient with an anxiety disorder related to diabetes. Behav Res Ther. 2004;42:357–66.CrossRefPubMed
45.
Amsberg S, Anderbro T, Wredling R, et al. A cognitive behavior therapy-based intervention among poorly controlled adult type 1 diabetes patients—a randomized controlled trial. Patient Educ Couns. 2009;77:72–80.CrossRefPubMed
46.
Gilbert RE, Fulcher G. Reduction in fear of hypoglycemia in subjects with sub-optimally controlled diabetes using a glargine insulin-based treatment regimen. Can J Diabetes. 2008;32:101–6.CrossRef
47.
Cox DJ, Gonder-Frederick L, Polonsky W, et al. Blood glucose awareness training (BGAT-2): long-term benefits. Diabetes Care. 2001;24:637–42.CrossRefPubMed
48.
Little SA, Leelarathna L, Walkinshaw E, et al. Recovery of hypoglycemia awareness in long-standing type 1 diabetes: a multicenter 2 × 2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose self-monitoring (HypoCOMPaSS). Diabetes Care. 2014;37:2114–22.CrossRefPubMed
49.
Choudhary P, Rickels MR, Senior PA, et al. Evidence-informed clinical practice recommendations for treatment of type 1 diabetes complicated by problematic hypoglycemia. Diabetes Care. 2015;38:1016–29.CrossRefPubMedPubMedCentral
50.
Barnard KD, Wysocki T, Allen JM, et al. Closing the loop overnight at home setting: psychosocial impact for adolescents with type 1 diabetes and their parents. BMJ Open Diabetes Res Care. 2014;2, e000025.CrossRefPubMedPubMedCentral
51.
Ziegler C, Liberman A, Nimri R, et al. Reduced worries of hypoglycaemia, high satisfaction, and increased perceived ease of use after experiencing four nights of MD-Logic artificial pancreas at home (DREAM4). J Diabetes Res. 2015;2015:590308.CrossRefPubMedPubMedCentral
52.
Barnard K, Parkin C, Young A, et al. Use of an automated bolus calculator reduces fear of hypoglycemia and improves confidence in dosage accuracy in patients with type 1 diabetes mellitus treated with multiple daily insulin injections. J Diabetes Sci Technol. 2012;6:144–9.CrossRefPubMedPubMedCentral
53.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study G, Beck RW, Lawrence JM, et al. Quality-of-life measures in children and adults with type 1 diabetes: Juvenile Diabetes Research Foundation Continuous Glucose Monitoring randomized trial. Diabetes Care. 2010;33:2175–7.CrossRef
54.
Hajos TR, Polonsky WH, Pouwer F, et al. Toward defining a cutoff score for elevated fear of hypoglycemia on the hypoglycemia fear survey worry subscale in patients with type 2 diabetes. Diabetes Care. 2014;37:102–8.CrossRefPubMed
55.
Patton SR, Dolan LM, Smith LB, et al. Pediatric parenting stress and its relation to depressive symptoms and fear of hypoglycemia in parents of young children with type 1 diabetes mellitus. J Clin Psychol Med Settings. 2011;18:345–52.CrossRefPubMedPubMedCentral
56.
Markowitz JT, Pratt K, Aggarwal J, et al. Psychosocial correlates of continuous glucose monitoring use in youth and adults with type 1 diabetes and parents of youth. Diabetes Technol Ther. 2012;14:523–6.CrossRefPubMedPubMedCentral
57.
Vallis M, Jones A, Pouwer F. Managing hypoglycemia in diabetes may be more fear management than glucose management: a practical guide for diabetes care providers. Curr Diabetes Rev. 2014;10:364–70.
Metadata
Title
Fear of Hypoglycemia in Children and Adolescents and Their Parents with Type 1 Diabetes
Authors
Kimberly A. Driscoll
Jennifer Raymond
Diana Naranjo
Susana R. Patton
Publication date
01-08-2016
Publisher
Springer US
Published in
Current Diabetes Reports / Issue 8/2016
Print ISSN: 1534-4827
Electronic ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-016-0762-2

Other articles of this Issue 8/2016

Current Diabetes Reports 8/2016 Go to the issue

Psychosocial Aspects (S Jaser and KK Hood, Section Editors)

Stress and A1c Among People with Diabetes Across the Lifespan

Psychosocial Aspects (S Jaser and KK Hood, Section Editors)

Social Disorder in Adults with Type 2 Diabetes: Building on Race, Place, and Poverty

Pathogenesis of Type 2 Diabetes and Insulin Resistance (RM Watanabe, Section Editor)

What Have Metabolomics Approaches Taught Us About Type 2 Diabetes?

Pediatric Type 2 Diabetes (PS Zeitler, Section Editor)

An Integrative Analysis of the Effect of Lifestyle and Pharmacological Interventions on Glucose Metabolism in the Prevention and Treatment of Youth-Onset Type 2 Diabetes

Economics and Policy in Diabetes (ES Huang and AA Baig, Section Editors)

International Models of Care that Address the Growing Diabetes Prevalence in Developing Countries

Treatment of Type 1 Diabetes (M Pietropaolo, Section Editor)

Management of Type 1 Diabetes in Pregnancy
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits